EACR AACR SIC:The challenges of optimising immuno and targeted therapies – from cancer biology to clinic

Print Friendly, PDF & Email

24-27 giugno

Firenze, Italia

EACR AACR SIC:The challenges of optimising immuno and targeted therapies – from cancer biology to clinic

Abstract: 318 – NMS-P088 is a small molecule potent CSF1R kinase inhibitor with macrophages immunomodulatory activity

Share this page

Facebook
Twitter
LinkedIn
Email
svg.e-font-icon-svg {display:none!important} .elementor-button-icon {display:none!important} .show-more, .show-more2 {display:none!important} img.pf-large-image.pf-primary-img.flex-width.pf-size-full.blockImage { display: none!important; }